Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 28, 2022
Methods for the economic evaluation of obesity prevention dietary interventions in children: A systematic review and critical appraisal of the evidence
Sundus Mahdi, Colette Marr, Nicola J Buckland, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 27, 2004
Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients
Michael Holmes, Jim Chilcott, Stephen Walters, et al.
BMC Medicine
|
December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
BMC Medicine
|
February 5, 2017
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
Pharmacoeconomics
|
January 3, 2025
Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness
Olena Mandrik, Chloe Thomas, Edifofon Akpan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2006
Methodological issues in the economic analysis of cancer treatments
Paul Tappenden, Jim Chilcott, Sue Ward, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 26, 2013
Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
International Journal of Surgery (London, England)
|
April 28, 2007
Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction
Yolanda Bravo Vergel, Jim Chilcott, Eva Kaltenthaler, et al.
BMJ Public Health
|
June 27, 2025
Cost-effectiveness of FIT and a FIT-based model to optimise symptomatic diagnosis of colorectal cancer: health economic modelling for the COLOFIT project
Chloe Thomas, Olena Mandrik, Jim Chilcott, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 28, 2022
Methods for the economic evaluation of obesity prevention dietary interventions in children: A systematic review and critical appraisal of the evidence
Sundus Mahdi, Colette Marr, Nicola J Buckland, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 27, 2004
Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients
Michael Holmes, Jim Chilcott, Stephen Walters, et al.
BMC Medicine
|
December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
BMC Medicine
|
February 5, 2017
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
Pharmacoeconomics
|
January 3, 2025
Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness
Olena Mandrik, Chloe Thomas, Edifofon Akpan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2006
Methodological issues in the economic analysis of cancer treatments
Paul Tappenden, Jim Chilcott, Sue Ward, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 26, 2013
Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
International Journal of Surgery (London, England)
|
April 28, 2007
Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction
Yolanda Bravo Vergel, Jim Chilcott, Eva Kaltenthaler, et al.
BMJ Public Health
|
June 27, 2025
Cost-effectiveness of FIT and a FIT-based model to optimise symptomatic diagnosis of colorectal cancer: health economic modelling for the COLOFIT project
Chloe Thomas, Olena Mandrik, Jim Chilcott, et al.
Page
of 4